FTC Drops Hammer On Warner Chilcott

Law360, New York (October 26, 2006, 12:00 AM EDT) -- In a blow to Warner Chilcott Ltd., the Federal Trade Commission has forbidden the pharmaceutical giant from entering into pacts where generic drug makers agree not to compete with its products, part of the recently brokered settlement over blockbuster birth control drug Ovcon 35.

The terms of the deal came to light on Wednesday, with the FTC revealing the various restrictions it had placed upon the Bermuda-based specialty pharmaceutical company.

On Friday, Warner Chilcott Ltd. agreed to settle the antitrust lawsuit brought last year by the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.